| Literature DB >> 29211780 |
Giuditta Fiorella Schiavano1, Elisa Carloni2, Francesca Andreoni2, Silvia Magi3, Maria Chironna4, Giorgio Brandi1, Giulia Amagliani1.
Abstract
SCOPE: This study aimed to analyse the prevalence, antibiotic resistance and genetic relatedness of P. aeruginosa isolates obtained from potable and recreational water samples (n. 8,351) collected from different settings (swimming pools, n. 207; healthcare facilities, n 1,684; accommodation facilities, n. 1,518; municipal waterworks, n. 4,500; residential buildings, n. 235). Possible mechanisms underlying resistance to imipenem, with particular focus on those involving oprD-based uptake, were also explored. METHODS ANDEntities:
Mesh:
Substances:
Year: 2017 PMID: 29211780 PMCID: PMC5718518 DOI: 10.1371/journal.pone.0189172
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primers used for sequencing.
| Name | 5’-3’ | Strains |
|---|---|---|
| oprD_PCR F | All strains | |
| oprD_PCR R | All strains | |
| oprD_seq F | All strains | |
| oprD_seq R | All strains | |
| oprD_seq F2 | All strains | |
| oprD_seq R2 | All strains | |
| oprD_seq F3 | All strains | |
| oprD_seq R4 | 16/PN/12, 53/PN/13, 482/PA/15 | |
| oprD_seq F5 | 482/PA/15 | |
| oprD_seq R5 | 482/PA/15 | |
| oprD_seq F6 | 482/PA/15 | |
| oprD_seq R6 | 482/PA/15 | |
| oprD_seq F7 | 16/PN/12, 53/PN/13 | |
| oprD_seq R7 | 16/PN/12, 53/PN/13 | |
| oprD_seq R8 | 16/PN/12 | |
Isolates used for sequence analysis of oprD gene: 4/PN/12, 10/PN/12, 13/PN/12, 16/PN/12, 25/PN/12, 33/PN/12, 37/PN/13, 53/PN/13, 10/PN/14, 7/PN/15, and 482/PA/15.
Prevalence of Pseudomonas aeruginosa in water samples from different locations.
| Location | N° | Tot. water samples | Positive samples | Prevalence (%) |
|---|---|---|---|---|
| 207 | ||||
| pool water | 153 | 5 | 3.26 | |
| inlet water | 54 | 5 | 9.2 | |
| 1684 | ||||
| 1518 | ||||
| 4500 | ||||
| 235 | ||||
| Total | 152 | 8351 | 53 | 0.63% |
Results of susceptibility testing of Pseudomonas aeruginosa (n = 53 isolates) of each antibiotic used.
| Disk content (μg) | Zone diameter breakpoint | Susceptible | Resistant | ||||
|---|---|---|---|---|---|---|---|
| S ≥ | R < | N. (%) | Inhibition zone Ø | N. (%) | Inhibition zone Ø | ||
| Piperacillin | 30 | 18 | 18 | 52 (98.11) | 24.6 ± 2.13 | 1 (1.88) | 14 ± 1.00 |
| Piperacillin+Tazobactam | 30–6 | 18 | 18 | 53 (100) | 25.8 ± 1.65 | 0 | - |
| Ticarcillin + Clavulanate | 75–10 | 18 | 18 | 51 (96.22) | 25.8 ± 2.17 | 2 (3.77) | 12.8 ± 2.54 |
| Ticarcillin | 75 | 18 | 18 | 53 (100) | 24.8 ± 3.46 | 0 | - |
| Cefepime | 30 | 19 | 19 | 53 (100) | 28.0 ± 2.35 | 0 | - |
| Ceftazidime | 10 | 16 | 16 | 53 (100) | 25.2 ± 2.71 | 0 | - |
| Doripenem | 10 | 25 | 22 | 53 (100) | 35.2 ± 4.52 | 0 | - |
| Imipenem | 10 | 20 | 17 | 48 (90.56) | 29.6 ± 2.02 | 5 (9.43) | 13.2 ± 1.40 |
| Meropenem | 10 | 24 | 18 | 53 (100) | 34.7 ± 6.15 | 0 | - |
| Aztreonam | 30 | 50 | 16 | 53 (100) | 29.5 ± 2.31 | 0 | - |
| Ciprofloxacin | 5 | 25 | 22 | 53 (100) | 36.6 ± 2.96 | 0 | - |
| Levofloxacin | 5 | 20 | 17 | 53 (100) | 30.0 ± 2.49 | 0 | - |
| Amikacin | 30 | 18 | 15 | 53 (100) | 23.3 ± 2.40 | 0 | - |
| Gentamicin | 10 | 15 | 15 | 53 (100) | 18.6 ± 2.17 | 0 | - |
| Tobramycin | 10 | 16 | 16 | 53 (100) | 24.7 ± 1.95 | 0 | - |
| Netilmicin | 10 | 12 | 12 | 53 (100) | 15.2 ± 2.59 | 0 | - |
Data of susceptible (S) or resistant (R) isolates according to EUCAST clinical breakpoint (www.eucast.org). Average of three experiments. Isolates with intermediate susceptibility are included into the “susceptible” category.
Fig 1Dendrogram of random amplified polymorphic DNA (RAPD) analysis of 53 P. aeruginosa isolates.
UPGMA clustering produced 12 groups at an arbitrary similarity level of 22% (Jaccard’s coefficient, dotted line). The methodology, using primer 272, revealed great diversity in genotypes (n = 45), identifying 37 unique genotypes and 8 clones.
Different OprD types and mechanisms of imipenem resistance detected among the P. aeruginosa isolates.
| Imipenem resistance phenotype | Isolates | Alteration(s) of | Alteration(s) or amino acidic substitution(s) of OprD sequence | Effect on OprD protein |
|---|---|---|---|---|
| 4/PN/12, 25/PN/12, 33/PN/12, 37/PN/13 | Several polymorphisms | D43N, S57E, | Full length type | |
| 10/PN/14 | Several polymorphisms | T103S, | Full length type | |
| 7/PN/15 | Several polymorphisms | S57E, S59R, | Full length type | |
| 10/PN/12, 13/PN/12 | Several polymorphisms | D43N, T103S, | ||
| 16/PN/12, 53/PN/13 | Insertion of 1239 nt at position 215 nt | Premature stop codon and porin loss | ||
| 482/PA/15 | Several polymorphisms | S57E, S59R, V127L | Premature stop codon and porin loss |
aIn bold, mutations which determine a charge change
+/-: K115T, V127L, V189T, A267S, V359L, Q424E
-/+: S59R, E185Q, E202Q, E230K, T276A, S403A
+/neutral: P186G, A281G, R310G, A315G